CN104736695B - 非致病性f18大肠杆菌菌株及其用途 - Google Patents

非致病性f18大肠杆菌菌株及其用途 Download PDF

Info

Publication number
CN104736695B
CN104736695B CN201380038666.XA CN201380038666A CN104736695B CN 104736695 B CN104736695 B CN 104736695B CN 201380038666 A CN201380038666 A CN 201380038666A CN 104736695 B CN104736695 B CN 104736695B
Authority
CN
China
Prior art keywords
strain
coli strain
coli
animals
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380038666.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN104736695A (zh
Inventor
约翰·莫里斯·费尔布勒特
埃里克·纳多
克拉里斯·德索泰尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilanko Canada Ltd
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Publication of CN104736695A publication Critical patent/CN104736695A/zh
Application granted granted Critical
Publication of CN104736695B publication Critical patent/CN104736695B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201380038666.XA 2012-07-20 2013-07-18 非致病性f18大肠杆菌菌株及其用途 Active CN104736695B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
US61/674,179 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (2)

Publication Number Publication Date
CN104736695A CN104736695A (zh) 2015-06-24
CN104736695B true CN104736695B (zh) 2017-05-24

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380038666.XA Active CN104736695B (zh) 2012-07-20 2013-07-18 非致病性f18大肠杆菌菌株及其用途

Country Status (17)

Country Link
US (3) US9453195B2 (https=)
EP (1) EP2875121B1 (https=)
JP (1) JP6278960B2 (https=)
KR (1) KR102171028B1 (https=)
CN (1) CN104736695B (https=)
BR (1) BR112015001175B1 (https=)
CA (1) CA2879155C (https=)
DK (1) DK2875121T3 (https=)
ES (1) ES2663019T3 (https=)
HU (1) HUE036545T2 (https=)
MX (1) MX363057B (https=)
PH (1) PH12015500091A1 (https=)
PL (1) PL2875121T3 (https=)
PT (1) PT2875121T (https=)
RS (1) RS57056B1 (https=)
RU (1) RU2670882C9 (https=)
WO (1) WO2014012172A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104736695B (zh) 2012-07-20 2017-05-24 普瑞特克微生物有限责任公司 非致病性f18大肠杆菌菌株及其用途
RU2722036C2 (ru) * 2015-02-11 2020-05-26 Превтек Майкробиа Инк. Усовершенствованная сухая матрица для встраивания жизнеспособных escherichia coli, способ ее получения и ее использования
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
EP3468382A4 (en) * 2016-06-14 2020-01-22 Prevtec Microbia Inc ANIMAL FEED PELLETS WITH FEED ADDITIVE, METHOD FOR THE PRODUCTION AND USE THEREOF
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
EP1100950A4 (en) * 1998-07-30 2002-10-16 Wisconsin Alumni Res Found GASTROINTESTINAL BACTERIAL ANTIBODY PLANTS
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
AU2100402A (en) 2000-11-30 2002-06-11 Bio Balance Corp Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
WO2004033646A2 (en) 2002-10-04 2004-04-22 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
HUE024565T2 (hu) * 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
CN104736695B (zh) 2012-07-20 2017-05-24 普瑞特克微生物有限责任公司 非致病性f18大肠杆菌菌株及其用途

Also Published As

Publication number Publication date
RS57056B1 (sr) 2018-05-31
US20160361369A1 (en) 2016-12-15
RU2015105738A (ru) 2016-09-10
EP2875121B1 (en) 2018-01-03
PT2875121T (pt) 2018-03-14
WO2014012172A1 (en) 2014-01-23
US20150152377A1 (en) 2015-06-04
US9775867B2 (en) 2017-10-03
CN104736695A (zh) 2015-06-24
EP2875121A4 (en) 2016-01-13
ES2663019T3 (es) 2018-04-10
CA2879155A1 (en) 2014-01-23
BR112015001175B1 (pt) 2022-03-03
JP6278960B2 (ja) 2018-02-14
KR102171028B1 (ko) 2020-10-28
CA2879155C (en) 2024-04-30
KR20150036698A (ko) 2015-04-07
EP2875121A1 (en) 2015-05-27
US10258654B2 (en) 2019-04-16
PH12015500091B1 (en) 2015-03-02
RU2670882C9 (ru) 2018-12-11
HUE036545T2 (hu) 2018-07-30
DK2875121T3 (en) 2018-04-16
HK1209780A1 (en) 2016-04-08
MX2015000905A (es) 2015-09-28
US9453195B2 (en) 2016-09-27
RU2670882C2 (ru) 2018-10-25
US20180008651A1 (en) 2018-01-11
MX363057B (es) 2019-03-06
JP2015525566A (ja) 2015-09-07
PL2875121T3 (pl) 2018-06-29
BR112015001175A2 (pt) 2017-06-27
PH12015500091A1 (en) 2015-03-02

Similar Documents

Publication Publication Date Title
CN104736695B (zh) 非致病性f18大肠杆菌菌株及其用途
Hayakawa et al. Dietary administration of probiotics to sows and/or their neonates improves the reproductive performance, incidence of post‐weaning diarrhea and histopathological parameters in the intestine of weaned piglets
Kyriakis et al. The effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets
Wu et al. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli
Barrow Probiotics for chickens
US8496923B2 (en) Probiotic treatment for infectious gastrointestinal diseases
US9861665B2 (en) Use of UVE bacteria for growth promotion in animals
Unterweger et al. Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
Charbonneau Controlling E. coli in the weaned pig.
CN118556072A (zh) 抗菌肽
Pereira et al. Fatores de virulência da Escherichia coli associados à importância da vacinação nos suínos
Nhi et al. SWINE COLIBACILLOSIS IN PIG
Thornton Siderophore receptor and porin protein-based vaccine technology: an intervention strategy for pre-harvest control of Escherichia coli O157 in cattle
Cox Identification of the receptor for F18+ E. coli: new perspectives towards development of a prophylactic treatment against F18+ E. coli infections in pigs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210305

Address after: Charlottetown Canada

Patentee after: Ilanko Canada Ltd.

Address before: Kaisan ohokkatsu

Patentee before: PREVTEC MICROBIA Inc.

TR01 Transfer of patent right